Case Series

Title Average Ratingsort ascending
The Deep Gluteal Syndrome, an underestimated etiological factor for Sciatica, Low Back Pain and other chronic pain conditions? 100.00%
Association of Hydroxychloroquine use and Hemolytic Anemia in Patients With Low Levels of Glucose-6-Phosphate Dehydrogenase 100.00%
A Study on the Relevance of Glucose-6-Phosphate Dehydrogenase Level Screening in Patients with Rheumatic Diseases Prior to Initiating Treatment With Hydroxychloroquine 95.00%
Reducing malignant ascites accumulation by repeated intraperitoneal administrations of a Viscum album extract. 95.00%
Patient satisfaction with primary care: an observational study comparing anthroposophic and conventional care 90.00%
Hyperthermia and radiation therapy for locally advanced or recurrent breast cancer. 90.00%
Retrospective study of Ukrain treatment in 203 patients with advanced-stage tumors 90.00%
Antiangiogenic metronomic chemotherapy and hyperthermia in the palliation of advanced cancer. 90.00%
Revisiting the ALA/N (alpha-lipoic acid/low-dose naltrexone) protocol for people with metastatic and nonmetastatic pancreatic ca 90.00%
Ozone therapy for patients with COVID-19 pneumonia: a Quasi-Randomized Controlled Trial 90.00%
Artesunate in the treatment of metastatic uveal melanoma--first experiences. 90.00%
Bevacizumab for recurrent ependymoma. 80.00%
Metformin use and prostate cancer in Caucasian men: results from a population-based case-control study. 80.00%
Infections Resulting from Narcotic Addiction 80.00%
MMS Study on Malaria is a Success 80.00%
Treatment of locally advanced pancreatic cancer with concurrent uftoral and radiotherapy. Results from 64 patients treated from 80.00%
Potential therapeutic efficacy of Ukrain (NSC 631570) in AIDS patients with Kaposi's sarcoma 80.00%
Anthroposophic health care--different and home-like. 80.00%
Why Ventilators May Not Be Working as Well for COVID-19 Patients as Doctors Hoped 80.00%
To widen the setting of cancer patients who could benefit from metronomic capecitabine. 80.00%
Clinical studies of Ukrain in terminal cancer patients (phase II) 80.00%
The clinical efficacy of adjuvant systemic chemotherapy with gemcitabine and NSC-631570 in advanced pancreatic cancer. 75.00%
Multiple cycles of intermittent chemotherapy in metastatic androgen-independent prostate cancer. 70.00%
Homeopathy as a supportive therapy in cancer. 70.00%
Repurposing Disulfiram in the Treatment of Lyme Disease and Babesiosis: Retrospective Review of First 3 Years’ Experience in One Medical Practice 70.00%
Clinical-translational strategies for the elevation of Nm23-H1 metastasis suppressor gene expression. 70.00%
Chelidonium majus L. (Ukrain) in the treatment of cancer patients. 63.33%
Evaluation of Ukrain as an immunostimulant in patients with various carcinomas. 63.33%
Ukrain both as an anti cancer and immunoregulatory agent 60.00%
Preliminary studies on the effect of Ukrain on the immunological response in patients with malignant tumours. 60.00%
Oral methotrexate for recurrent brain tumors in children: a Pediatric Oncology Group study. 60.00%
The effects of thiophosphoric acid (Ukrain) on cervical cancer, stage IB bulky 60.00%
Early outcomes following low dose naltrexone enhancement of opioid detoxification. 60.00%
Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer 60.00%
Lymphocyte subsets in patients with lung cancer treated with thiophosphoric acid 55.00%
Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryother 50.00%
Real world treatment patterns of gastrointestinal stromal tumor patients. 50.00%
Results of Ukrain monotherapy of prostate cancer 50.00%
Do Recurrent and Metastatic Pancreatic Cancer Patients Have the Same Outcomes with Gemcitabine Treatment? 50.00%
Long term outcomes following surgical resection of myxopapillary ependymomas. 40.00%
Mistletoe in conventional oncological practice: exemplary cases. 40.00%
A retrospective analysis of locally advanced esophageal cancer patients treated with neoadjuvant chemoradiation therapy followe 30.00%
Effective Treatment of Glioblastoma Multiforme With Oncolytic Virotherapy: A Case-Series